In Utero Genome Editing: Potential and Politics
Objectives and Disclosures
Participants will be able to:
- Assess an emerging opportunity in genome editing therapy.
- Analyze various criteria by which to determine when in utero editing would be appropriate.
- Outline the ethical and political challenges associated with in utero editing.
Planners disclose they have no relevant financial relationships. Speaker intends to discuss investigational efforts with fetal gene therapy and is also an academic consultant at UCSF.
All relevant financial relationships have been mitigated.
R. Alta Charo, JD
Warren P. Knowles Professor Emerita of Law & Bioethics at the University of Wisconsin
Seattle Children’s is accredited by the Washington State Medical Association CME Accreditation Committee to sponsor continuing medical education for physicians.
Seattle Children’s designates this online educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
This activity meets the criteria for up to 1 hour of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
Videos are available for only one year after posting.
If you wish to receive Category I CME credit for viewing this Provider Grand Rounds session, please complete the evaluation form. Upon completion of the form you will receive an auto-reply email that will serve as the only confirmation of your CME credit. Please keep the email for your records.